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Abstract 
The objective of this study was to disclose the expression of Proliferative 
Cell Nuclear Antigen (PCNA) and apoptosis on white rat’s liver cells due to 
oxidative process produced by different dosages and exposure times of Aflatoxin 
B1 biotransformation. Using factorial design in this experimental study three 
exposure times and four dosages of AFB1 were used. The experiment used 96 
white rats. Adult healthy white rats were divided into four groups of 24 rats each, 
based on the dosages of AFB, given. Each groups was divided further into three 
sub groups of eight rats based on the leghth of exposure time to AFB1. 
Four dosages of AFB1, were introduced orally every day into different groups, 
consisted of 0, 10, 15 and 20 ug, dissolved in 0.2 ml propylene glicol. Three 
subgroup received the dosage for 12 weeks, 16 weeks and 20 weeks. At the end of 
the experiment, the rats were sacrificed. Liver cells with PCNA were scrutinized 
using immunohistochemical method, using ovidin biotin method (DAKO) and 
apoptosis were determined by using peroxidase insitu detection kit, while liver 
cell damage were examined using histological slices stained by haematoxillin 
eosin. 
Our data confirmed that : 1) Expression of PCNA were significant differences 
between no exposure AFB1  with 16 weeks and 15 µg AFB1 exposure (a time that 
dysplacia started). The expression become increase by the increasing dosages and 
time exposure of AFB1. 2) Expression of apoptosis become increased until 16 
weeks and 15 µg AFB1 exposure (a time that dysplacia started), but after that 
there is no increase anymore by the increasing dosage and time exposure AFB1. 
This study conclude that the expression of apoptosis become increase until a time 
dysplacia started, and then they will decrease, while PCNA become increase after 
a time where dysplacias  started. 
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Introduction 
Aflatoxin Bι (AFBι) is a potent 
toxin, mutagen, and carcinogen, and is 
implicated in the etiology of 
hepatocarcinoma. Its carcinogenic 
effect has been confirmed by long study 
in several animal species.
(1)
 In human, 
exposure to dietary aflatoxin through 
the consumptions of stored food stuffs 
which are infected by Aspergillums has 
been implicated in the high incidence of 
primary liver cancer. A cohort study in 
the high-risk areas in eastern China, 
found a positive linear relationship 
between AFBι level in food stuffs and 
mortality attributable to primary liver 
cancer.
(2)
 
AFBι is relatively non-reactive 
until it is ingested and covered by liver 
enzyme
1
. In the liver, it undergoes 
biotransformation into different 
metabolites catalyzed by citochrome P-
450.
(3)
 Production of reactive oxygen 
species (ROS) is the side effect of P-
450 catalization. Moreover, in the body, 
ROS will damage three important 
components which are responsible for 
maintaining cell integrity, including 
lipids, protein, and DNA.
(4)
 Shen et al., 
(1995) found that 8-hydroxy deoxy 
guanosine (8.OH dg) formation 
increased significantly in the liver cell 
of rats AFBι treated group. 8. OH dg is 
one of specific and representative forms 
of the oxidative DNA damage induced 
by ROS.
(5)
 
In responding to the DNA 
damage, normal tissue cells are 
instructed by p53 either to perform 
DNA repair or to undergo apoptosis.
(6)
 
p21 Cip 1 or Waf 1 is a key mediator of 
the growth arrest induced by p53. p21 
induction after DNA damage may lead 
to inhibition of cell cycle progression 
and inactivation of PCNA-dependent 
DNA replication, while permitting 
active nucleotide excision repair.
(7)
 If 
the cells are failed to repair, p53 
activate the death promoting genes such 
as bax and fas to induce apoptosis.
(8, 9)
 
AFBι, which produces ROS, 
causes cellular stress. In general, it 
initiates apoptosis via the involvement 
of mitochondria. The relative ratios of 
various bcl-2 proteins can often 
determine how much cellular stress is 
necessary to induce apoptosis.
(10)
 
Proliferating cell nuclear antigen 
(PCNA) is an essential protein involved 
in the replication of genomic DNA.
(11)
 
It is an auxiliary protein which presents 
during G1-late and S phase, by binding 
to DNA polymerases delta and is 
clearly correlated with cells cycle. 
Therefore, it has been propagated as a 
proliferation marker.
(12)
 The increase of 
PCNA expression was detected in the 
human tumors in a wide variety of 
organs, including colon, lung, bladder, 
ovary, liver, skin, and simpatico 
nervous system.
(7,13-17)
  
Although the expression of 
apoptosis and PCNA are different 
things, there is a correlation between 
the expression of apoptosis and PCNA 
on the development of cancer. Because 
of that, the aim of this research is to 
study the expression of PCNA and 
apoptosis on liver cells damage due to 
oxidative process of AFBι 
biotransformation.  
 
Materials and Methods 
1. Chemicals 
AFBι was purchased from sigma 
grade A-6636 Saint Louis USA. 
Apoptosis detection kit and 
mouse mono clonal anti rat for 
PCNA were purchased from 
DAKO L SAB 2. 
2. Animals 
Ninety-six male white rats 
(Rattus norvegicus) were 
purchased from animal center of 
Gajah Mada University. They 
were divided into four groups of 
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24 rats. Each group was given 
different dosages of AFBι. AFBι 
which was dissolved in 0.2 ml 
of propylene glycol was 
administered orally everyday for 
each group with different 
dosages; 0 µg, 10 µg, 15 µg, and 
20 µg. Moreover, they were 
divided further into 3 subgroups 
of 8 rats based on the length of 
the exposure time to AFBι; 12 
weeks, 16 weeks, and 20 weeks. 
At the end of the experiment, 
the rats were sacrificed and the 
liver fixed in 4% neutral 
formalin. 
3. Expression of apoptosis 
Expression of apoptosis was 
detected with peroxides in situ 
apoptosis detection kit. 
Resected specimens were 
routinely fixed within 40 g/l 
formal dehyde solution 
immediately after the resection. 
Then, paraffin blocks were 
prepared. After paraffin was 
removed from the slices, the 
preparations were incubated 
with 20 µg/ml proteinase K for 
15 minutes and rinsed with d 
H2O for 5 minutes. Endogenous 
peroxides activity was blocked 
with 15% H2O2 for 5 minutes 
and rinsed with PBS. The 
preparation was subsequently 
reacted with equilibrium buffer 
for 10 seconds and then was 
reacted with 50 µl TdT mixture 
at 37ºC for 1 hour. The reaction 
was stopped by putting the 
preparation into a pot which 
contained stop buffer reaction 
for 10 minutes. At the room 
temperature, then, the 
preparation was subsequently 
rinsed with PBS (pH 7.4) for 5 
minutes, digoxigenin conjugate 
for 30 minutes, and PBS again 
for 5 minutes. After being rinsed 
with PBS, the preparation was 
treated with DAB chromogen 
(diametro benzidine) solution 
for 3 to 5 minutes, then rinsed 
with running water and added to 
a nuclear staining solution, 
dehydrated and mounted. 
Apoptosis cells were examined 
by light microscope and were 
stained as dark-brown. It was 
counted up to 100 cells and 
positive apoptosis cells were 
calculated. 
4. Expression of PCNA 
A section was cut from the 
paraffin blocks. Endogenous 
peroxides activity was blocked 
with 30 ml/l hydrogen peroxide 
at room temperature for 5 to 10 
minutes. The preparation was 
subsequently treated into 600 w 
microwave oven for 5 minutes 
and into 0.01 mol/l citric acid 
buffer (pH 6.0), which is 
repeated three times. After 
blocking with goat serum, every 
section was added with 50 µl 
mouse monoclonal primary 
antibodies for PCNA at 37ºC for 
1 to 2 hours. Sections were 
incubated with second-antibody 
PCNA biotin conjugated at a 
dilution of 1:400 and then, 
rinsed with PBS (pH 7.4) for 5 
minutes. Signal was visualized 
using the streptavidin-biotin 
peroxides method and then, 
rinsed with PBS (pH 7.4) for 5 
minutes. The slides were 
counter stained with Meyer 
hemotoxilin, then dehydrated 
and mounted. The positive 
specimen of PCNA was defined 
as cells with stained nuclear and 
non-stained plasma. It was 
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counted up to 100 cells and cells 
with PCNA expression were 
calculated. 
5.   Determine liver cells damage 
 To determine liver cells damage, 
we used histological slices 
stained by haematoxillin eosin. 
Evaluation of the damage of 
liver cells only focused on the 
uncontrolled growth of cells 
(cancer or dysplacias cells)   
 
 
 
 
 
 
 
  
Results 
1. Expression of apoptosis 
Expression of apoptosis on the liver cells and their statistic significantly 
using Tukey HSD are shown by table 1, 2, and 3, and figure 1 and 2.  
 
Table 1. Apoptosis on the liver cells based on the length and dosages of AFBι 
given 
 
The length of 
time of AFBι 
given 
The dosages of AFBι given (µg) 
0 10 15 20 
mean Mean Mean Mean 
12 weeks 0.54 ± 0.31 5.38 ± 1.77 6.38 ± 2.13  7.75 ± 2.25 
16 weeks 0.38 ± 0.29 10.5 ± 2.67 9.13 ± 2.74 9.13 ± 2.36 
20 weeks 0.25 ± 0.16 8.0   ± 1.77 7.38 ± 2.10 7.75 ± 2.05 
 
Table 1 shows that apoptosis had occurred in the dosage 0 µg at 12, 16, and 20 
weeks (normal feeding without AFBι). The number of apoptosis increased as the 
dosage and the length of AFBι given increased, peaking at dosage 10 µg and 16 
weeks.  
 
Table 2. Tukey HSD of apoptosis expression on the liver cells based on the 
dosages of AFBι given 
 
 The dosages of AFBι given (µg) 
0 10 15 20 
Apoptosis cells 0.37
a 
8.13
b 
7.79
b 
8.21
b 
SD 0.28 2.95 2.52 2.23 
 
The different superscripts on table 2 shows a significant differences of apoptosis 
expression caused by different dosages given (p < 0.05). Indeed, there is a 
significant difference of apoptosis expression between superscript a (dosage 0) 
and superscript b (10, 15, and 20 µg). But, there is no significant differences 
among dosages 10, 15, and 20 µg. 
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Figure 1. Apoptosis expression on the liver cells based on 
dosages AFB1 given
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Figure 1 shows that the number of apoptosis cells increased as the dosage of AFBι 
given increased and reached a peak at dosage 10 µg. At dosages 15 and 20 µg, the 
number of apoptosis cells decreased. However, this decline was not different 
significantly. 
 
Table 3. Tukey HSD of apoptosis expression on the liver cells based on the 
length of AFBι given 
 
 The length of AFBι given (weeks) 
12 16 20 
Apoptosis cells 5.00
a 
7.28
b 
6.09
a 
SD 3.26 4.63 3.81 
 
The different superscripts on table 3 shows a significant differences of apoptosis 
expression caused by different length of AFBι given. Apoptosis expression on the 
group who got AFBι for 16 weeks is different significantly with the group who 
got AFBι for 12 and 20 weeks. 
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Figure 2. apoptosis expression on the liver cells based on the 
length of AFB1 given
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Figure 2 shows that apoptosis had occurred at the length of AFBι given 12 weeks, 
reached a peak at 16 weeks, and then decreased. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Apoptosis detection on the liver cells after AFBι given (400x) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Apoptosis detection on the liver cells after AFBι given (1000x) 
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2. Expfression of PCNA 
Expression of PCNA on the liver cells and their statistic significantly 
using Tukey HSD are shown by table 4, 5, and 6, and figure 5 and 6.  
 
Table 4. PCNA on the liver cells based on the length and dosages of AFBι 
given. 
 
The length of 
time of AFBι 
given 
The dosages of AFBι given (µg) 
0 10 15 20 
mean Mean Mean Mean 
12 weeks 2.72 ± 0.84 2.14 ± 1.62 1.02 ± 0.40  0.98 ± 0.64 
16 weeks 2.62 ± 0.54 2.09 ± 0.54 4.82 ± 1.72 6.04 ± 1.98 
20 weeks 2.84 ± 1.92 2.92  ± 
1.01 
6.08 ± 3.07 8.98 ± 4.52 
 
Table 4 shows that PCNA had occurred in the dosage 0 µg at 12, 16, and 20 
weeks (normal feeding without AFBι). The number of PCNA decreased as the 
dosage and the length of AFBι given increased until dosage 15 µg 12 weeks. 
Expression of PCNA increased by adding more dosage (20 µg) and longer 
administering (16 and 20 weeks).   
 
Table 5. Tukey HSD of PCNA expression on the liver cells based on the 
dosages of AFBι given 
 
 The dosages of AFBι given (µg) 
0 10 15 20 
Expression of PCNA 2.72
a 
2.38
a 
4.31
b 
5.33
b 
SD 1.66 0.48 1.93 2.04 
 
The different superscripts on table 5 shows a significant differences of PCNA 
expression caused by different dosages given (p < 0.05). Indeed, there is a 
significant difference of PCNA expression between superscript a (dosage 0 and 10 
µg) and superscript b (15 and 20 µg).  
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Figure 5. PCNA expression on the liver cells based on 
dosages AFB1 given
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Figure 5 shows that the expression of PCNA on the liver cells had occurred at 
dosage AFBι given 0 µg. It decreased and reach minimum point at dosage 10 µg 
before increasing at dosages 15 and 20 µg. 
 
Table 6. Tukey HSD of PCNA expression on the liver cells based on the 
length of AFBι given 
 
 The length of AFBι given 
(weeks) 
12 16 20 
Expression of PCNA 1.70
a 
4.25
b 
5.01
b 
SD 0.62 1.86 2.94 
 
The different superscripts on table 6 shows a significant differences of PCNA 
expression caused by different length of AFBι given. PCNA expression on the 
group who got AFBι for 12 weeks is different significantly with the group who 
got AFBι for 16 and 20 weeks. 
 
Figure 6. PCNA expression on the liver cells based on the 
length of AFB1 given
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Figure 6 shows that expression of PCNA increased by the adding of the length of 
AFBι given. 
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Figure 7. Expression of PCNA on the liver cells after AFBι given (400x) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Expression of PCNA on the liver cells after AFBι given (1000x) 
 
3. Expfression of cancer cells or dysplacia cells 
By using histological slices, we examined the expression of cancer cells. 
Unfortunately, we could not find any cancer cells. We only found the 
dysplacia cells. Dysplacia cells on the liver cells and their statistic 
significantly using Tukey HSD are shown by table 7, 8, nd 9 and figure 9 
and 10.  
 
Table 7. Dysplacia cells on the liver cells based on the length and dosages of 
AFBι given. 
 
The length of 
time of AFBι 
given 
The dosages of AFBι given (µg) 
0 10 15 20 
mean Mean Mean mean 
12 weeks 0 ± 0.00 0 ± 0.00 0 ± 0.00  0 ± 0.00 
16 weeks 0 ± 0.00 0 ± 0.00 3.38 ± 1.84 5.62 ± 3.16 
20 weeks 0 ± 0.00 0.88  ± 0.44 5.88 ± 4.36 8.63 ± 6.94 
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Table 7 shows that dysplacia occurred in the dosage 15 µg at 16weeks. The 
number of dysplacia cells increased as the dosage and the length of AFBι given 
increased.  
 
Table 8. Tukey HSD of dysplacia cells on the liver cells based on the dosages 
of AFBι given 
 
 The dosages of AFBι given (µg) 
0 10 15 20 
Dysplacia cells 0
a 
0.62
a 
3.08
b 
4.75
b 
SD 0 0.29 2.59 3.34 
 
The different superscripts on table 8 shows a significant differences of the number 
of dysplacia cells caused by different dosages given (p < 0.05). Indeed, there is a 
significant difference of the number of dysplacia cells between superscript a 
(dosage 0 and 10 µg) and superscript b (15 and 20 µg).  
 
Figure 9. Dysplacia cells on the liver cells based on dosages 
AFB1 given
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Figure 9 shows that the dysplacia cells on the liver cells occurred at dosage AFBι 
given 10 µg. Its number increased by dosage increased. 
 
Table 9. Tukey HSD of dysplacia cells on the liver cells based on the length of 
AFBι given 
 
 The length of AFBι given 
(weeks) 
12 16 20 
Dysplacia cells 0
a 
2.25
b 
3.84
c 
SD 0 1.48 2.13 
 
The different superscripts on table 9 shows a significant differences of the number 
of dysplacia cells caused by different length of AFBι given. Each group is 
different significantly.  
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Figure 10. Dysplacia cells on the liver cells based on the 
length of AFB1 given
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Figure 10 shows that the dysplacia cells occurred on the liver after 12 weeks of 
AFBι given and their number increased by the length of AFBι given increased. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Dysplacia on the liver cells after AFBι given (400x) 
 
Discussion 
Apoptosis is an essential 
component to maintain homeostasis of 
tissues both in normal development and 
in eliminating diseases or damage cells. 
Our study showed that apoptosis had 
occurred at normal feeding (0 µg of 
AFBι given). This could happen 
because of normal process, or because 
of exposure to other toxic chemicals 
that caused cells to undergo apoptosis in 
order to retain tissues’ homeoestasis. 
AFBι is a potent toxin, mutagen, 
and carcinogen which is transformed 
into different metabolites by citochrome 
P-450. Side effect of P-450 catalization 
is reactive oxygen species (ROS) which 
causes oxydative damage of DNA, 
protein, and lipid peroxide as proved by 
Narasimhan et al., (2000), Yanwirasti 
(2004) and Shen et al., (1995).
(5,18,19)
 
The increasing production of 
ROS which is caused by the presence of 
AFBι, suppresses antioxidant in the 
body. The imbalance of ROS and 
antioxidant produces oxidative stress. It 
has been proven in our study that AFBι 
suppressed superoxyde and catalase 
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enzyme of liver tissue and increased 
malondialdehyde which damaged liver 
cells.
(19)
 In general, damaged liver cells 
caused by the oxidative stress initiate 
apoptosis via the involvement of 
mitochondria.
(10)
 
Mitochondria plays an important 
role in the regulation of apoptosis 
caused by the oxidative stress. It 
contains many pro-apoptotic proteins 
such as Apoptosis Inducing Factor 
(AIF), Smac/DIABLO, and cytochrome 
C. These factors are released from 
mitochondria following the formation 
of a pore in the mitochondria membrane 
called the permeability transition pore 
or PT pore. These pores are formed 
through the action of the pro-apoptotic 
members of the bcl-2 family proteins, 
which in turn are activated by oxidative 
stress of the liver cells. These proteins 
cause cytochrome C to leak out and 
bind to the apaf.1 and activate caspase-
9. The activation of these caspases 
creates proteolytic activity which leads 
cell to apoptosis.
(20)
 
Pore opening of inner 
mitochondria membrane allows the 
movement of CA
+2 
from mitochondria 
and results in rising intracellular Ca 
levels which activates Ca
+2 
dependent 
endonucleosis and leads DNA 
fragmentation, an important factor in 
apoptosis.
(21)
 
In our study, we found that 
apoptosis on the liver cells increased 
until the dosage 10 µg and 16 weeks of 
AFBι given. The significant differences 
of apoptosis were shown between 
dosage 10 µg, 16 weeks of AFBι given, 
and both dosage 10 µg, 12 weeks of 
AFBι given and dosage 20 µg, 12 
weeks of AFBι given (p<0,05). But, 
there was no increasing apoptosis on the 
liver cells by the increasing dosages and 
the length of AFBι given. It means that 
the mechanism of apoptosis is not only 
caused by the damage of mitochondria, 
but also by the activity of tumor 
suppressor gene p-53. 
Exposure of ROS which is 
produced by bioactivity of AFBι leds to 
a noticeable rise of p-53 protein. It has 
been demonstrated by Yang and 
Hughes in 1998, that exposure of 20 
µg/ml AFBι for 16 h on NCTC 929 
mouse fibroblast cells induced p-53 
protein which was analyzed by both 
Elisa and Western Blot. See et al., 
(2001)
(22)
 found that wt p-53 was an 
inducer of apoptotic cell death in human 
hepatoma cell lines. 
AFBι is known to be a major 
risk factor for the development of 
hepatocellular carcinomas (HCC) in 
many areas in the world. It has been 
postulated to be a hepatocarcinogen in 
human by P-53 mutation.
(2)
 An animal 
experiment had shown that AFBι which 
induced  rat liver tumor and 
preneoplastic lesion enhanced p-53 
point mutation. p-53 mutation causes 
defect in the p-53 function and resistant 
to apoptosis induction.
(23)
 The 
resistance can be acquired by cancer 
cells through a variety of strategies. The 
most commonly strategy is p-53 
mutation.
(22)
 The defect in p-53 function 
is important step in carcinogenesis 
because it disrupts apoptosis and 
initiates tumor. 
In our study, we found that 
apoptosis decreased at dosage 15 µg 
and 16 weeks AFBι given. At the same 
time, we found dysplacia on the liver 
cells. Dysplacia is an abnormal 
organization of cells, in addiction to 
excessive proliferation. The off spring 
of this cell appears abnormal in shape 
and in orientation. Dysplacia begin 
when some cells within a normal 
population sustaines a genetic 
mutation.
(24)
 Table 9 and figure 10 
shows that the more AFBι induction, 
the more dysplacia we had. It is 
different with apoptosis in which the 
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more AFBι induction, the less apoptosis 
we had. So, the mechanism of apoptosis 
on the liver cells inducing by AFBι 
happens in two ways: the role of 
mitochondria and the role of p-53 gene. 
PCNA was originally identified 
as an antigen that was expressed in the 
nuclear of cells during DNA synthesis 
phase of the cell cycle. DNA 
polymerase delta has a proof reading 
activity and is expected to play a 
significant role in the maintanance of 
the fidelity of mammalian DNA 
replication. PCNA is clamped to DNA 
through the action of replicator factor C 
(RFC) and helps in holding DNA 
polymerase delta to DNA.
(25)
 
Responding to DNA damage, p-
21 Cip 1 is a key mediator of the 
growth arrest induced by the tumor 
suppressor protein p-53. p-21 induction 
after DNA damage leads to inhibition of 
cells cycle progression and inactivation 
of PCNA-dependent DNA replication.
(7)
 
AFBι induces rat liver tumor and 
enhances p-53 point mutation which 
causes defect in the p-53 function. The 
defect of its function, causes p-53 fails 
to induce p-21 inhibiting PCNA 
function. 
In our study, we detected the 
expression of PCNA on the liver cells. 
It increased at dosage 15 µg and the 
length of 16 weeks of AFBι given. It 
was contrast to the expression of 
apoptosis whereas apoptosis decreased 
at dosage 15 µg and the length of 16 
weeks of AFBι given. This means that 
there was a defect of the p-53 function 
in regulating apoptosis in order to 
response to DNA damage. As 
consequently, p-53 failed in inducing p-
21 to inhibite PCNA function. It was 
shown in our study that the expression 
of PCNA increased after dosage 15 µg 
and the length of 16 weeks of AFBι 
given. At the same time, dysplacia 
occurred on the liver cells. It increased 
by increasing dosage and length of 
AFBι given. The expression of 
dysplacia means that AFBι developes 
preneoplastic lesion. Qin et al., (2005) 
also found that proliferation index by 
counting PCNA was higher in the tissue 
of liver cancer than in its adjacent non 
cancerous tissue.
(15)
 
We conclude that AFBι is a risk 
factor for the development of hepato 
cellular carcinomas through p-53 
mutation which in turn p-21 is failed to 
be induced. This results in decreasing of 
apoptosis expression and increasing 
PCNA expression. 
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